Bulgaria vs Oman: HIV-positive TB patients on ART (antiretroviral therapy)
Bulgaria
100.0%
in 2020
Oman
100.0%
in 2024
Bulgaria rank
1st
Oman rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bulgaria
- Oman
How they compare
Bulgaria currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 4 times across 6 shared years of data; in 2010 it was Oman ahead.
Bulgaria ranks 1st and Oman ranks 1st of 144 countries.
Bulgaria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 89.6% | 10.4% | Bulgaria |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bulgaria or Oman?
- Bulgaria, at 100.0% against 100.0% in Oman as of 2020.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bulgaria and Oman?
- 0.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Oman?
- 6 years are reported by both, from 2010 to 2020.
- How do Bulgaria and Oman rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bulgaria ranks 1st and Oman ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.